Skip to content

Clinical trials

Completed Neoplasm Metastasis trials in Taiwan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasm Metastasis Status: Completed Country / region: Taiwan Clear all

60 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20031
20041
20061
20073
20083
20095
20102
20111
20126
20134
20146
20155
20164
20174
20184
20191
20201
20213
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed60

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca5
Novartis Pharmaceuticals5
Eli Lilly and Company3
National Taiwan University Hospital3
Pfizer3
AbbVie2
Amgen2
Bayer2
EMD Serono Research & Development Institute, Inc.2
PharmaEngine2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasm Metastasis60
Breast Neoplasms15
Neoplasms14
Carcinoma, Non-Small-Cell Lung10
Stomach Neoplasms6
Lung Neoplasms5
Pancreatic Neoplasms5
Recurrence5
Adenocarcinoma4
Esophageal Neoplasms4

Trials

Showing 1 to 25 of 60. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.